COGENT BIOSCIENCES INC's ticker is COGT and the CUSIP is 19240Q201. A total of 136 filers reported holding COGENT BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,393,285 | -19.5% | 142,901 | -2.2% | 0.00% | – |
| Q2 2023 | $1,730,511 | -57.1% | 146,158 | -60.9% | 0.00% | – |
| Q1 2023 | $4,034,436 | +33.5% | 373,905 | +43.0% | 0.00% | – |
| Q4 2022 | $3,021,853 | +6.2% | 261,406 | +37.1% | 0.00% | – |
| Q3 2022 | $2,845,000 | +587.2% | 190,727 | +315.3% | 0.00% | – |
| Q2 2022 | $414,000 | +55.6% | 45,920 | +29.2% | 0.00% | – |
| Q1 2022 | $266,000 | -19.9% | 35,541 | -8.1% | 0.00% | – |
| Q4 2021 | $332,000 | -10.3% | 38,680 | -12.2% | 0.00% | – |
| Q3 2021 | $370,000 | +160.6% | 44,063 | +151.2% | 0.00% | – |
| Q2 2021 | $142,000 | -35.7% | 17,540 | -30.3% | 0.00% | – |
| Q1 2021 | $221,000 | +49.3% | 25,160 | +90.8% | 0.00% | – |
| Q4 2020 | $148,000 | – | 13,188 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 1,558,975 | $17,507,000 | 6.26% |
| COMMODORE CAPITAL LP | 760,025 | $8,535,000 | 4.64% |
| Ally Bridge Group (NY) LLC | 1,622,591 | $18,222,000 | 3.12% |
| Ghost Tree Capital, LLC | 1,100,000 | $12,353,000 | 2.75% |
| Logos Global Management LP | 1,920,500 | $21,567,000 | 1.85% |
| Altium Capital Management LP | 432,563 | $4,858,000 | 1.81% |
| VR Adviser, LLC | 1,088,817 | $12,227,000 | 1.80% |
| Atlas Venture Associates IX, LLC | 916,196 | $10,289,000 | 1.63% |
| Atlas Venture Associates XI, LLC | 916,196 | $10,289,000 | 1.63% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 235,066 | $2,640,000 | 1.53% |